| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
12,428,000 |
| Market
Cap: |
63.63(M) |
| Last
Volume: |
3,820 |
Avg
Vol: |
3,810 |
| 52
Week Range: |
$4.23 - $9.78 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Delivery |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ProPhase Labs is a company that provides a range of services including diagnostic testing, genomics testing and contract manufacturing. Co. conduct its operations through two operating segments: diagnostic services and consumer products. The diagnostic services segment provides SARS-CoV-2 diagnostic information services to a range of customers in the U.S., including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products and dietary supplements in the U.S. and also provides personal genomics products and services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Leventhal Mark S |
Director |
– • – |
2015-11-30 |
4/A |
B |
$1.48 |
$1,403 |
D/D |
948 |
881,980 |
2.31 |
- |
|
| Leventhal Mark S |
Director |
– • – |
2015-11-30 |
4 |
A |
$1.48 |
$1,403 |
D/D |
948 |
881,980 |
|
- |
|
| Leventhal Mark S |
Director |
– • – |
2015-11-27 |
4/A |
B |
$1.55 |
$20,615 |
D/D |
13,300 |
881,032 |
2.39 |
- |
|
| Leventhal Mark S |
Director |
– • – |
2015-11-27 |
4 |
A |
$1.55 |
$20,615 |
D/D |
13,300 |
881,032 |
|
- |
|
| Leventhal Mark S |
Director |
– • – |
2015-11-25 |
4/A |
B |
$1.30 |
$22,428 |
D/D |
17,252 |
867,732 |
2.39 |
- |
|
| Leventhal Mark S |
Director |
– • – |
2015-11-25 |
4 |
A |
$1.30 |
$22,428 |
D/D |
17,252 |
867,732 |
|
- |
|
| Leventhal Mark S |
Director |
– • – |
2015-11-24 |
4/A |
B |
$1.30 |
$24,050 |
D/D |
18,500 |
850,480 |
2.39 |
- |
|
| Leventhal Mark S |
Director |
– • – |
2015-11-24 |
4 |
A |
$1.30 |
$24,050 |
D/D |
18,500 |
850,480 |
|
- |
|
| Leventhal Mark S |
Director |
– • – |
2015-08-18 |
4 |
A |
$1.61 |
$233,947 |
D/D |
145,309 |
832,180 |
|
- |
|
| Leventhal Mark S |
Director |
– • – |
2015-08-17 |
4 |
A |
$1.61 |
$329,553 |
D/D |
204,691 |
686,671 |
|
- |
|
| Barr Jason Michael |
Director |
– • – |
2015-06-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,100 |
|
- |
|
| Leventhal Mark S |
Director |
– • – |
2015-06-08 |
4 |
A |
$1.40 |
$100,059 |
D/D |
71,471 |
481,980 |
|
- |
|
| Leventhal Mark S |
Director |
– • – |
2015-06-05 |
4 |
A |
$1.31 |
$168,373 |
D/D |
128,529 |
410,509 |
|
- |
|
| Karkus Ted William |
See Remarks |
• • • |
2015-06-04 |
4 |
B |
$1.30 |
$260,000 |
D/D |
200,000 |
2,674,588 |
3.23 |
- |
|
| Karkus Ted William |
CEO & Chairman |
• • • |
2015-05-19 |
4 |
B |
$1.35 |
$269,330 |
D/D |
199,504 |
2,474,588 |
3.23 |
- |
|
| Karkus Ted William |
CEO & Chairman |
• • • |
2015-05-18 |
4 |
B |
$1.34 |
$14,065 |
D/D |
10,496 |
2,275,084 |
3.15 |
- |
|
| Gleckel Louis Md |
Director |
– • – |
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,295 |
79,235 |
|
- |
|
| Mccubbin James T |
Director |
– • – |
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,147 |
31,829 |
|
- |
|
| Leventhal Mark S |
Director |
– • – |
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,295 |
281,980 |
|
- |
|
| Frank Mark Shawn |
Director |
– • – |
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,295 |
79,235 |
|
- |
|
| Burnett Mark A. |
Director |
– • – |
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,295 |
310,808 |
|
- |
|
| Karkus Ted William |
CEO & Chairman |
• • • |
2014-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
2,264,588 |
|
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2014-11-07 |
4 |
B |
$1.38 |
$19,245 |
I/I |
13,946 |
2,322,627 |
1.5 |
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2014-11-06 |
4 |
B |
$1.37 |
$10,275 |
I/I |
7,500 |
2,308,681 |
1.5 |
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2014-11-05 |
4 |
B |
$1.32 |
$57,156 |
I/I |
43,300 |
2,301,181 |
1.5 |
- |
|
191 Records found
|
|
Page 3 of 8 |
|
|
0.07 (1.39%) 
